The additional contribution of combination of pharmacological therapy and cognitive stimulation in Alzheimer's disease: Review of the literature

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Alzheimer.s disease (AD) is a progressive disorder that impacts several cognitive functions. However, some aspects of cognitive function are preserved until later in the disease and can therefore be the targets of specific interventions. The rehabilitation of cognitive function disorders represents an expanding area of neurological rehabilitation and it has recently attracted growing political, social and ethical attention. Here we review the efficacy of combining cognitive stimulation and cholinesterase inhibitors. Generally, all the studies reported in this review have compared the combined treatment with pharmacological intervention alone. Further studies should clarify the potential role of the combined cognitive-pharmacological treatment in AD persons with dementias care. In the meantime, the findings of the studies reviewed in this paper suggest that cognitive rehabilitation should be an essential part of dementia treatment, along with antidementia drugs.

Original languageEnglish
Title of host publicationNon-Pharmacological Therapies in Different Types of Dementia and Mild Cognitive Impairment: A Wide Perspective from Theory to Practice
PublisherNova Science Publishers, Inc.
Pages73-81
Number of pages9
ISBN (Print)9781633218789, 9781633218604
Publication statusPublished - Oct 1 2014

Keywords

  • Alzheimer's disease (AD)
  • Combined cognitive-pharmacological treatment
  • Rehabilitation of cognitive function disorders

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'The additional contribution of combination of pharmacological therapy and cognitive stimulation in Alzheimer's disease: Review of the literature'. Together they form a unique fingerprint.

Cite this